Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
Med Biol Eng Comput ; 61(6): 1533-1548, 2023 Jun.
Article in English | MEDLINE | ID: mdl-36790640

ABSTRACT

Biomechanics plays a critical role in coronary artery disease development. FSI simulation is commonly used to understand the hemodynamics and mechanical environment associated with atherosclerosis pathology. To provide a comprehensive characterization of patient-specific coronary biomechanics, an analysis of FSI simulation in the spatial and temporal domains was performed. In the current study, a three-dimensional FSI model of the LAD coronary artery was built based on a patient-specific geometry using COMSOL Multiphysics. The effect of myocardial bridging was simulated. Wall shear stress and its derivatives including time-averaged wall shear stress, wall shear stress gradient, and OSI were calculated across the cardiac cycle in multiple locations. Arterial wall strain (radial, circumferential, and longitudinal) and von Mises stress were calculated. To assess perfusion, vFFR was calculated. The results demonstrated the FSI model could identify regional and transient differences in biomechanical parameters within the coronary artery. The addition of myocardial bridging caused a notable change in von Mises stress and an increase in arterial strain during systole. The analysis performed in this manner takes greater advantage of the information provided in the space and time domains and can potentially assist clinical evaluation.


Subject(s)
Coronary Vessels , Myocardial Bridging , Humans , Coronary Vessels/pathology , Biomechanical Phenomena , Myocardial Bridging/pathology , Models, Cardiovascular , Hemodynamics , Computer Simulation , Spatio-Temporal Analysis , Stress, Mechanical
2.
Diagnostics (Basel) ; 12(12)2022 Nov 25.
Article in English | MEDLINE | ID: mdl-36552955

ABSTRACT

Volumetric measurements with cardiac magnetic resonance imaging (MRI) are effective for evaluating heart failure (HF) with systolic dysfunction that typically induces a lower ejection fraction (EF) than normal (<50%) while they are not sensitive to diastolic dysfunction in HF patients with preserved EF (≥50%). This work is to investigate whether HF evaluation with cardiac MRI can be improved with real-time MRI feature tracking. In a cardiac MRI study, we recruited 16 healthy volunteers, 8 HF patients with EF < 50% and 10 HF patients with preserved EF. Using real-time feature tracking, a cardiac MRI index, torsion correlation, was calculated which evaluated the correlation of torsional and radial wall motion in the left ventricle (LV) over a series of sequential cardiac cycles. The HF patients with preserved EF and the healthy volunteers presented significant difference in torsion correlation (one-way ANOVA, p < 0.001). In the scatter plots of EF against torsion correlation, the HF patients with EF < 50%, the HF patients with preserved EF and the healthy volunteers were well differentiated, indicating that real-time MRI feature tracking provided LV function assessment complementary to volumetric measurements. This study demonstrated the potential of cardiac MRI for evaluating both systolic and diastolic dysfunction in HF patients.

3.
J Cardiovasc Magn Reson ; 24(1): 23, 2022 04 04.
Article in English | MEDLINE | ID: mdl-35369885

ABSTRACT

BACKGROUND: While multiple cardiovascular magnetic resonance (CMR) methods provide excellent reproducibility of global circumferential and global longitudinal strain, achieving highly reproducible segmental strain is more challenging. Previous single-center studies have demonstrated excellent reproducibility of displacement encoding with stimulated echoes (DENSE) segmental circumferential strain. The present study evaluated the reproducibility of DENSE for measurement of whole-slice or global circumferential (Ecc), longitudinal (Ell) and radial (Err) strain, torsion, and segmental Ecc at multiple centers. METHODS: Six centers participated and a total of 81 subjects were studied, including 60 healthy subjects and 21 patients with various types of heart disease. CMR utilized 3 T scanners, and cine DENSE images were acquired in three short-axis planes and in the four-chamber long-axis view. During one imaging session, each subject underwent two separate DENSE scans to assess inter-scan reproducibility. Each subject was taken out of the scanner and repositioned between the scans. Intra-user, inter-user-same-site, inter-user-different-site, and inter-user-Human-Deep-Learning (DL) comparisons assessed the reproducibility of different users analyzing the same data. Inter-scan comparisons assessed the reproducibility of DENSE from scan to scan. The reproducibility of whole-slice or global Ecc, Ell and Err, torsion, and segmental Ecc were quantified using Bland-Altman analysis, the coefficient of variation (CV), and the intraclass correlation coefficient (ICC). CV was considered excellent for CV ≤ 10%, good for 10% < CV ≤ 20%, fair for 20% < CV ≤ 40%, and poor for CV > 40. ICC values were considered excellent for ICC > 0.74, good for ICC 0.6 < ICC ≤ 0.74, fair for ICC 0.4 < ICC ≤ 0.59, poor for ICC < 0.4. RESULTS: Based on CV and ICC, segmental Ecc provided excellent intra-user, inter-user-same-site, inter-user-different-site, inter-user-Human-DL reproducibility and good-excellent inter-scan reproducibility. Whole-slice Ecc and global Ell provided excellent intra-user, inter-user-same-site, inter-user-different-site, inter-user-Human-DL and inter-scan reproducibility. The reproducibility of torsion was good-excellent for all comparisons. For whole-slice Err, CV was in the fair-good range, and ICC was in the good-excellent range. CONCLUSIONS: Multicenter data show that 3 T CMR DENSE provides highly reproducible whole-slice and segmental Ecc, global Ell, and torsion measurements in healthy subjects and heart disease patients.


Subject(s)
Heart Diseases , Magnetic Resonance Imaging, Cine , Healthy Volunteers , Heart Diseases/diagnostic imaging , Humans , Magnetic Resonance Imaging, Cine/methods , Magnetic Resonance Spectroscopy , Predictive Value of Tests , Reproducibility of Results
4.
Radiol Med ; 126(9): 1159-1169, 2021 Sep.
Article in English | MEDLINE | ID: mdl-34132927

ABSTRACT

BACKGROUND: Quantification of left atrial late gadolinium enhancement is a powerful clinical and research tool. Fibrosis burden has been shown to predict the success of pulmonary vein isolation, post-ablation reoccurrence, and major adverse cardiovascular events such as stroke. OVERVIEW: The standardized cardiovascular magnetic resonance imaging protocols 2020 update describes the key components of the examination. This review is a more in-depth guide, geared toward building left atrial late gadolinium enhancement imaging from the ground up. The standard protocol consists of the following: localization, pulmonary vein magnetic resonance angiography, cardiac cines, left ventricular, and atrial late gadolinium enhancement. We also review typical segmentation and post-processing techniques, as well as discuss pitfalls, limitations, and potential future innovations in this area. CONCLUSIONS: With sufficient experience and optimized protocols, left atrial late gadolinium enhancement imaging is a strong addition to the cardiac magnetic resonance imaging repertoire.


Subject(s)
Contrast Media , Gadolinium , Heart Atria/diagnostic imaging , Image Enhancement , Magnetic Resonance Imaging/methods , Atrial Fibrillation/etiology , Fibrosis/complications , Fibrosis/diagnostic imaging , Heart Atria/pathology , Humans , Image Processing, Computer-Assisted , Magnetic Resonance Angiography/methods
5.
J Cardiovasc Magn Reson ; 23(1): 20, 2021 03 11.
Article in English | MEDLINE | ID: mdl-33691739

ABSTRACT

BACKGROUND: Cardiovascular magnetic resonance (CMR) cine displacement encoding with stimulated echoes (DENSE) measures heart motion by encoding myocardial displacement into the signal phase, facilitating high accuracy and reproducibility of global and segmental myocardial strain and providing benefits in clinical performance. While conventional methods for strain analysis of DENSE images are faster than those for myocardial tagging, they still require manual user assistance. The present study developed and evaluated deep learning methods for fully-automatic DENSE strain analysis. METHODS: Convolutional neural networks (CNNs) were developed and trained to (a) identify the left-ventricular (LV) epicardial and endocardial borders, (b) identify the anterior right-ventricular (RV)-LV insertion point, and (c) perform phase unwrapping. Subsequent conventional automatic steps were employed to compute strain. The networks were trained using 12,415 short-axis DENSE images from 45 healthy subjects and 19 heart disease patients and were tested using 10,510 images from 25 healthy subjects and 19 patients. Each individual CNN was evaluated, and the end-to-end fully-automatic deep learning pipeline was compared to conventional user-assisted DENSE analysis using linear correlation and Bland Altman analysis of circumferential strain. RESULTS: LV myocardial segmentation U-Nets achieved a DICE similarity coefficient of 0.87 ± 0.04, a Hausdorff distance of 2.7 ± 1.0 pixels, and a mean surface distance of 0.41 ± 0.29 pixels in comparison with manual LV myocardial segmentation by an expert. The anterior RV-LV insertion point was detected within 1.38 ± 0.9 pixels compared to manually annotated data. The phase-unwrapping U-Net had similar or lower mean squared error vs. ground-truth data compared to the conventional path-following method for images with typical signal-to-noise ratio (SNR) or low SNR (p < 0.05), respectively. Bland-Altman analyses showed biases of 0.00 ± 0.03 and limits of agreement of - 0.04 to 0.05 or better for deep learning-based fully-automatic global and segmental end-systolic circumferential strain vs. conventional user-assisted methods. CONCLUSIONS: Deep learning enables fully-automatic global and segmental circumferential strain analysis of DENSE CMR providing excellent agreement with conventional user-assisted methods. Deep learning-based automatic strain analysis may facilitate greater clinical use of DENSE for the quantification of global and segmental strain in patients with cardiac disease.


Subject(s)
Deep Learning , Heart Diseases/diagnostic imaging , Image Interpretation, Computer-Assisted , Magnetic Resonance Imaging, Cine , Ventricular Function, Left , Ventricular Function, Right , Automation , Case-Control Studies , Heart Diseases/physiopathology , Humans , London , Predictive Value of Tests , United States
6.
Am J Cardiol ; 124(9): 1449-1453, 2019 11 01.
Article in English | MEDLINE | ID: mdl-31493830

ABSTRACT

The goal of this study was to determine the predictors of adverse clinical outcomes in patients treated with the MitraClip for significant mitral regurgitation (MR) with a focus on acute changes in hemodynamics and cardiac function. This retrospective study included 63 patients (mean age 82 ± 8 years, 48% male) with moderate to severe or severe MR. Cardiac catheterization was performed before and immediately after MitraClip repair. Volumetric and functional changes were assessed in both ventricles. A major adverse cardiac event was defined as a composite of cardiac death and readmission for heart failure. Patients were followed up on average for 380 days. MR was improved in 92% of patients after MitraClip therapy from an average grade of 4+ to <2+ (p <0.001). The pulmonary capillary wedge pressure decreased from 22 ± 7 mm Hg to 19 ± 6 mm Hg (p <0.001), and the cardiac stroke volume increased by 28% from 102 ± 53 ml to 131 ± 54 ml (p <0.001). The left ventricular end-diastolic volume was significantly reduced 24 hours after MitraClip therapy compared to that at baseline (p = 0.001). In the multivariate Cox proportion hazard regression model, an age ≥85 years (p <0.001) and residual MR >1+ (p <0.048) were predictors of an adverse prognosis at follow-up. In conclusion, a reduced left ventricular end-diastolic volume and improved hemodynamics occurred early after MitraClip therapy. An advanced age (≥85 years) and residual MR >1+ were associated with an increased risk of mortality and heart failure.


Subject(s)
Heart Failure/epidemiology , Mitral Valve Annuloplasty , Mitral Valve Insufficiency/surgery , Mortality , Patient Readmission/statistics & numerical data , Age Factors , Aged , Aged, 80 and over , Female , Heart Diseases/mortality , Humans , Male , Multivariate Analysis , Prognosis , Proportional Hazards Models , Pulmonary Wedge Pressure , Retrospective Studies , Risk Factors , Severity of Illness Index , Stroke Volume , Surgical Instruments , Treatment Outcome
7.
J Cardiovasc Magn Reson ; 19(1): 23, 2017 Jan 20.
Article in English | MEDLINE | ID: mdl-28187739

ABSTRACT

BACKGROUND: With multifaceted imaging capabilities, cardiovascular magnetic resonance (CMR) is playing a progressively increasing role in the management of various cardiac conditions. A global registry that harmonizes data from international centers, with participation policies that aim to be open and inclusive of all CMR programs, can support future evidence-based growth in CMR. METHODS: The Global CMR Registry (GCMR) was established in 2013 under the auspices of the Society for Cardiovascular Magnetic Resonance (SCMR). The GCMR team has developed a web-based data infrastructure, data use policy and participation agreement, data-harmonizing methods, and site-training tools based on results from an international survey of CMR programs. RESULTS: At present, 17 CMR programs have established a legal agreement to participate in GCMR, amongst them 10 have contributed CMR data, totaling 62,456 studies. There is currently a predominance of CMR centers with more than 10 years of experience (65%), and the majority are located in the United States (63%). The most common clinical indications for CMR have included assessment of cardiomyopathy (21%), myocardial viability (16%), stress CMR perfusion for chest pain syndromes (16%), and evaluation of etiology of arrhythmias or planning of electrophysiological studies (15%) with assessment of cardiomyopathy representing the most rapidly growing indication in the past decade. Most CMR studies involved the use of gadolinium-based contrast media (95%). CONCLUSIONS: We present the goals, mission and vision, infrastructure, preliminary results, and challenges of the GCMR. TRIAL REGISTRATION: Identification number on ClinicalTrials.gov: NCT02806193 . Registered 17 June 2016.


Subject(s)
Cardiovascular Diseases/diagnostic imaging , Magnetic Resonance Imaging , Registries , Research Design , Societies, Scientific , Cardiovascular Diseases/pathology , Cardiovascular Diseases/physiopathology , Cardiovascular Diseases/therapy , Contrast Media/administration & dosage , Cooperative Behavior , Humans , International Cooperation , Internet/organization & administration , Organizational Objectives , Predictive Value of Tests , Prognosis
8.
J Am Heart Assoc ; 4(12)2015 Dec 08.
Article in English | MEDLINE | ID: mdl-26645833

ABSTRACT

BACKGROUND: Impaired pulmonary function (IPF) and left ventricular systolic dysfunction (LVSD) are prevalent in the elderly and are associated with significant morbidity and mortality. The main objectives of this study were to examine the relative impact and joint association of IPF and LVSD with heart failure, cardiovascular mortality and all-cause mortality, and their impact on risk classification using a continuous net reclassification index. METHODS AND RESULTS: We followed 2342 adults without prevalent cardiovascular disease (mean age, 76 years) from the Cardiovascular Health Study for a median of 12.6 years. LVSD was defined as LV ejection fraction <55%. IPF was defined as: forced expiratory volume in 1 second:forced vital capacity <70%, and predicted forced expiratory volume in 1 second <80%. Outcomes included heart failure hospitalization, cardiovascular mortality, all-cause mortality, and composite outcome. LVSD was detected in 128 subjects (6%), IPF in 441 (19%) and both in 38 (2%). Compared to those without LVSD or IPF, there was a significantly increased cardiovascular risk for groups of LVSD only, IPF only, and LVSD plus IPF, adjusted hazard ratio (95% CI) 2.1 (1.5-3.0), 1.7 (1.4-2.1), and 3.2 (2.0-5.1) for HF; 1.8 (1.2-2.6), 1.4 (1.1-1.8), and 2.8 (1.7-4.7) for cardiovascular mortality; 1.3 (1.0-1.8), 1.7 (1.4-1.9), and 2.1 (1.5-3.0) for all-cause mortality, and 1.6 (1.3-2.1), 1.7 (1.5-1.9), and 2.4 (1.7-3.3) for composite outcome, respectively. Risk classification improved significantly for all outcomes when IPF was added to the adjusted model with LVSD or LVSD to IPF. CONCLUSIONS: While risk of cardiovascular outcomes was the highest among elderly with both LVSD and IPF, risk was comparable between subjects with IPF alone and those with LVSD alone. This observation, combined with improved risk classification by adding IPF to LVSD or LVSD to IPF, underscore the importance of comprehensive heart and lung evaluation in cardiovascular outcome assessment.


Subject(s)
Heart Diseases/mortality , Lung Diseases/mortality , Ventricular Dysfunction, Left/mortality , Aged , Aged, 80 and over , Cardiovascular Diseases/mortality , Cardiovascular Diseases/physiopathology , Female , Heart Diseases/physiopathology , Heart Failure/mortality , Heart Failure/physiopathology , Hospitalization/statistics & numerical data , Humans , Kaplan-Meier Estimate , Lung Diseases/physiopathology , Male , Mortality , Prospective Studies , Respiratory Function Tests , Risk Assessment , Risk Factors , Stroke Volume , United States/epidemiology , Ventricular Dysfunction, Left/physiopathology
SELECTION OF CITATIONS
SEARCH DETAIL